Clinical trial
The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.
NCT04605627 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 8, 2020
- Completion date
- December 31, 2023
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, intestinal disease